SPINACI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.316
EU - Europa 738
AS - Asia 541
OC - Oceania 33
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 6
Totale 2.659
Nazione #
US - Stati Uniti d'America 1.267
CN - Cina 296
IT - Italia 184
GB - Regno Unito 140
DE - Germania 126
JP - Giappone 91
RU - Federazione Russa 58
FR - Francia 53
IN - India 36
CA - Canada 35
AU - Australia 33
HK - Hong Kong 32
PL - Polonia 30
NL - Olanda 22
ES - Italia 19
KR - Corea 19
VN - Vietnam 17
IE - Irlanda 16
BE - Belgio 13
AP - ???statistics.table.value.countryCode.AP??? 12
FI - Finlandia 10
UA - Ucraina 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
IR - Iran 9
MX - Messico 9
SG - Singapore 9
TW - Taiwan 8
BR - Brasile 6
CH - Svizzera 6
IL - Israele 6
SE - Svezia 6
LT - Lituania 5
RO - Romania 5
BD - Bangladesh 4
PT - Portogallo 4
CL - Cile 3
PK - Pakistan 3
PR - Porto Rico 3
AR - Argentina 2
CR - Costa Rica 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
IQ - Iraq 2
IS - Islanda 2
MA - Marocco 2
RS - Serbia 2
TR - Turchia 2
UY - Uruguay 2
ZA - Sudafrica 2
BG - Bulgaria 1
BY - Bielorussia 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 2.659
Città #
Houston 214
Fairfield 107
Ann Arbor 92
Ashburn 76
Cambridge 65
Santa Cruz 54
Shanghai 51
Camerino 49
Woodbridge 46
Seattle 43
Wilmington 37
Beijing 34
Wuhan 30
Buffalo 26
San Diego 22
Warsaw 22
Leawood 19
Dong Ket 16
Pavia 16
Tokyo 16
Dublin 15
Los Angeles 14
Milan 14
Jinan 13
Moscow 13
New York 13
Ottawa 13
Bengaluru 12
Falls Church 12
Sakurai 12
Centro 11
Chengdu 11
Guangzhou 11
Hangzhou 11
Columbus 10
Nanjing 10
London 9
Shenyang 9
Madrid 8
St Petersburg 8
Chicago 7
Las Vegas 7
Nürnberg 7
Paris 7
Toronto 7
Bendigo 6
Bologna 6
Frankfurt am Main 6
Hamburg 6
Linden 6
Maletto 6
Manchester 6
Melbourne 6
Milpitas 6
Mumbai 6
Nizhniy Novgorod 6
Osaka 6
Portland 6
San Francisco 6
Scafati 6
Amsterdam 5
Boulder 5
Brooklyn 5
Brussels 5
Central 5
Council Bluffs 5
Duncan 5
Florence 5
Helsinki 5
Hong Kong 5
Madison 5
Menlo Park 5
Taipei 5
Xian 5
Aachen 4
Boston 4
Crugers 4
Edinburgh 4
Gatchina 4
Gurgaon 4
Lake Forest 4
Minneapolis 4
Parsippany 4
Pittsburgh 4
Randwick 4
Richmond 4
San Jose 4
Sydney 4
Volgograd 4
Albuquerque 3
Austin 3
Barcelona 3
Basel 3
Berlin 3
Boardman 3
Bremen 3
Changchun 3
Clearwater 3
Dallas 3
Dhaka 3
Totale 1.552
Nome #
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications, file e0ff0074-2c06-9bac-e053-1705fe0af019 769
The G Protein-Coupled Receptor GPR17: Overview and Update, file e0ff0072-b0e8-9bac-e053-1705fe0af019 457
GPR17 receptor modulators and their therapeutic implications: review of recent patents, file e0ff0074-a9fe-9bac-e053-1705fe0af019 378
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity, file e0ff0073-da3e-9bac-e053-1705fe0af019 294
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor, file e0ff0072-b2fb-9bac-e053-1705fe0af019 211
New sensible method to quantize the intestinal absorption of receptor ligands, file e0ff0073-da40-9bac-e053-1705fe0af019 181
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview, file e0ff0073-f268-9bac-e053-1705fe0af019 96
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415d-9bac-e053-1705fe0af019 90
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415e-9bac-e053-1705fe0af019 70
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-9499-9bac-e053-1705fe0af019 65
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity, file e0ff0073-0c0b-9bac-e053-1705fe0af019 30
Pharmacological characterization of the GPR17 receptor dual profile, file e0ff0073-08ed-9bac-e053-1705fe0af019 17
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-0fb8-9bac-e053-1705fe0af019 17
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases, file 1b8ef5ed-7704-47fa-94d5-f5e9cbbfb953 16
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?, file e0ff0074-fba5-9bac-e053-1705fe0af019 6
A patent review of adenosine A2B receptor antagonists (2016-present), file 98ec94e8-7aff-4f03-aee8-17e3f5b17930 5
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists, file e0ff0074-9ad4-9bac-e053-1705fe0af019 5
Combined therapy of A1AR agonists and A2AAR antagonists in neuroinflammation, file e0ff0074-e319-9bac-e053-1705fe0af019 5
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis, file e0ff0074-9ad2-9bac-e053-1705fe0af019 4
P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications, file e0ff0074-e31b-9bac-e053-1705fe0af019 4
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies, file 45bfd3f8-8e53-4b40-ad7d-c867bdea19b0 3
Multipotent stromal cells from subcutaneous adipose tissue of normal weight and obese subjects: Modulation of their adipogenic differentiation by adenosine A1 receptor ligands, file e0ff0074-eb4c-9bac-e053-1705fe0af019 3
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders, file cffe90fd-e53d-443e-96fe-3c0428dc9f22 2
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0072-aa02-9bac-e053-1705fe0af019 2
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases, file e0ff0073-1500-9bac-e053-1705fe0af019 2
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases, file 59420ae7-5e97-4e1d-8aa4-2ee674ed2158 1
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists, file e0ff0072-61d6-9bac-e053-1705fe0af019 1
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA, file e0ff0073-14fe-9bac-e053-1705fe0af019 1
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0073-8dda-9bac-e053-1705fe0af019 1
New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity, file e0ff0074-a47d-9bac-e053-1705fe0af019 1
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity, file e0ff0074-dcbe-9bac-e053-1705fe0af019 1
Totale 2.738
Categoria #
all - tutte 5.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 10 6
2019/2020112 6 6 4 12 6 2 7 6 9 4 24 26
2020/2021552 17 17 32 22 36 46 73 42 51 71 74 71
2021/20221.049 92 105 65 194 137 77 71 47 43 60 107 51
2022/2023424 24 39 79 61 42 36 24 15 17 29 36 22
2023/2024552 56 71 43 53 74 34 43 45 54 44 35 0
Totale 2.738